Trial Profile

RIvoraxaban Safety and Efficacy in Patients With Mitral Stenosis

Status: Discontinued

Phase of Trial: Phase III

Latest Information Update: 04 Nov 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Rivaroxaban (Primary) ; Warfarin
Indications Stroke; Thromboembolism
Focus Therapeutic Use
Acronyms RISE MS

Most Recent Events

14 Aug 2021 Status changed from recruiting to discontinued.
14 Jun 2019 Planned End Date changed from 23 Apr 2020 to 23 Jun 2021.
14 Jun 2019 Planned primary completion date changed from 23 Apr 2020 to 22 May 2021.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com